Based on the key measurements obtained from Teva Pharma's financial statements, Teva Pharma Industries is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April. At present, Teva Pharma's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Stockholder Equity is expected to grow to about 9.8 B, whereas Total Assets are forecasted to decline to about 26.8 B. Key indicators impacting Teva Pharma's financial strength include:
The essential information of the day-to-day investment outlook for Teva Pharma includes many different criteria found on its balance sheet. An individual investor should monitor Teva Pharma's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Teva Pharma.
Please note, the presentation of Teva Pharma's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Teva Pharma's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Teva Pharma's management manipulating its earnings.
Teva Pharma Stock Summary
Teva Pharma competes with Haleon Plc, Bausch Health, Zoetis, Takeda Pharmaceutical, and Elanco Animal. Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Teva Pharmaceutical is traded on New York Stock Exchange in the United States.
Foreign Associate
Israel
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
Comparative valuation techniques use various fundamental indicators to help in determining Teva Pharma's current stock value. Our valuation model uses many indicators to compare Teva Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Teva Pharma competition to find correlations between indicators driving Teva Pharma's intrinsic value. More Info.
Teva Pharma Industries is rated below average in return on equity category among its peers. It is rated second in return on asset category among its peers . At present, Teva Pharma's Return On Equity is projected to slightly decrease based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Teva Pharma's earnings, one of the primary drivers of an investment's value.
Teva Pharma's Earnings Breakdown by Geography
Teva Pharma Industries Systematic Risk
Teva Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Teva Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Teva Pharma Industries correlated with the market. If Beta is less than 0 Teva Pharma generally moves in the opposite direction as compared to the market. If Teva Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Teva Pharma Industries is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Teva Pharma is generally in the same direction as the market. If Beta > 1 Teva Pharma moves generally in the same direction as, but more than the movement of the benchmark.
Teva Pharma Thematic Clasifications
Teva Pharma Industries is part of several thematic ideas from Adviser Favorites to Israel Wall Street. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic Ideas
Today, most investors in Teva Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Teva Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Teva Pharma growth as a starting point in their analysis.
Price Earnings To Growth Ratio
(0.0771)
At present, Teva Pharma's Price Earnings To Growth Ratio is projected to increase slightly based on the last few years of reporting.
Teva Pharma March 24, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Teva Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Teva Pharma Industries. We use our internally-developed statistical techniques to arrive at the intrinsic value of Teva Pharma Industries based on widely used predictive technical indicators. In general, we focus on analyzing Teva Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Teva Pharma's daily price indicators and compare them against related drivers.
When running Teva Pharma's price analysis, check to measure Teva Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Teva Pharma is operating at the current time. Most of Teva Pharma's value examination focuses on studying past and present price action to predict the probability of Teva Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Teva Pharma's price. Additionally, you may evaluate how the addition of Teva Pharma to your portfolios can decrease your overall portfolio volatility.